InsidersTradesSigma
Follow the 한국파마 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 한국파마 has recorded 56 insider filings. Market capitalisation: €87bn. The latest transaction was filed on 28 May 2026 (Other). Among the most active insiders: 박은희. All data is accessible without an account.
54
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Fundamental score
Ranked 25,402 of 29,156 companies
24.8
score / 100
Value25
Quality25
FCF yld1.7%
Earn yld-3.3%
EV/EBITDA53.3x
ROE-1.1%
Gross mgn36%
Net mgn-3.0%
Debt/EBITDA17.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 May 2026
Declarations56 total
Other
Other
25 of 56 declarations
About 한국파마
한국파마 is a company specializing in the health and pharmaceutical sector. It is listed on the XKRX market.